Our product reviews offer independent views with hands-on opinion and honest verdicts aimed to give you all the important information you need to make the best buying decisions.

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

See today's BioWorld MedTech Home » Boston Sci, Medtronic fare well in NICE review of remote monitoring X Upgrade your daily dose of biopharma and medtech news Subscribe to BioWorld™ news services See ...

Across the recent three months, 13 analysts have shared their insights on Medtronic MDT, expressing a variety of opinions spanning from bullish to bearish. The following table summarizes their ...

Medtronic has reported revenue gains across several of its medical device franchises ... at-home trial of people with ...

2 Medtronic Nellcor™ SpO2 device vs. Masimo SET™* SpO2 device In 2022, a leading hypoxemia research laboratory team evaluated device performance and accuracy of the Medtronic Nellcor™ SpO2 ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

Medtronic reported its second-quarter financial results for the fiscal year 2025, showing a 5.3% increase in total revenue, reaching $8.4 billion. The company also saw 5% growth in organic revenue, ...